Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 114 entries
Sorted by: Best Match Show Resources per page
Emerging therapies for the treatment of osteoporosis.

Journal of mid-life health

Bhutani G, Gupta MC.
PMID: 24672186
J Midlife Health. 2013 Jul;4(3):147-52. doi: 10.4103/0976-7800.118991.

Osteoporosis is a chronic disease of the osseous system characterized by decreased bone strength and increased fracture risk. It is due to an imbalance in the dynamic ongoing processes of bone formation and bone resorption. Currently available osteoporosis therapies...

Cite
Bhutani G, Gupta MC. Emerging therapies for the treatment of osteoporosis. J Midlife Health. 2013;4(3):147-52doi: 10.4103/0976-7800.118991.
Bhutani, G., & Gupta, M. C. (2013). Emerging therapies for the treatment of osteoporosis. Journal of mid-life health, 4(3), 147-52. https://doi.org/10.4103/0976-7800.118991
Bhutani, Garima, and Gupta, Mahesh Chander. "Emerging therapies for the treatment of osteoporosis." Journal of mid-life health vol. 4,3 (2013): 147-52. doi: https://doi.org/10.4103/0976-7800.118991
Bhutani G, Gupta MC. Emerging therapies for the treatment of osteoporosis. J Midlife Health. 2013 Jul;4(3):147-52. doi: 10.4103/0976-7800.118991. PMID: 24672186; PMCID: PMC3952405.
Copy Download .nbib Format: NLM
Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

Hip & pelvis

Min BW, Song KS, Bae KC, Cho CH, Son ES, Lee KJ.
PMID: 27536596
Hip Pelvis. 2015 Mar;27(1):9-16. doi: 10.5371/hp.2015.27.1.9. Epub 2015 Mar 31.

Osteoporosis is a metabolic disease that is increasing in prevalence as people live longer. Because the orthopedic surgeon is frequently the first and often the only physician to manage patients with osteoporotic hip fractures, every effort should be made...

Cite
Min BW, Song KS, Bae KC, et al. Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures. Hip Pelvis. 2015;27(1):9-16doi: 10.5371/hp.2015.27.1.9.
Min, B. W., Song, K. S., Bae, K. C., Cho, C. H., Son, E. S., & Lee, K. J. (2015). Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures. Hip & pelvis, 27(1), 9-16. https://doi.org/10.5371/hp.2015.27.1.9
Min, Byung-Woo, et al. "Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures." Hip & pelvis vol. 27,1 (2015): 9-16. doi: https://doi.org/10.5371/hp.2015.27.1.9
Min BW, Song KS, Bae KC, Cho CH, Son ES, Lee KJ. Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures. Hip Pelvis. 2015 Mar;27(1):9-16. doi: 10.5371/hp.2015.27.1.9. Epub 2015 Mar 31. PMID: 27536596; PMCID: PMC4972623.
Copy Download .nbib Format: NLM
Bone turnover markers: Emerging tool in the management of osteoporosis.

Indian journal of endocrinology and metabolism

Shetty S, Kapoor N, Bondu JD, Thomas N, Paul TV.
PMID: 27867890
Indian J Endocrinol Metab. 2016 Nov-Dec;20(6):846-852. doi: 10.4103/2230-8210.192914.

Bone is a dynamic tissue which undergoes constant remodeling throughout the life span. Bone turnover is balanced with coupling of bone formation and resorption at various rates leading to continuous remodeling of bone. A study of bone turnover markers...

Cite
Shetty S, Kapoor N, Bondu JD, et al. Bone turnover markers: Emerging tool in the management of osteoporosis. Indian J Endocrinol Metab. 2016;20(6):846-852doi: 10.4103/2230-8210.192914.
Shetty, S., Kapoor, N., Bondu, J. D., Thomas, N., & Paul, T. V. (2016). Bone turnover markers: Emerging tool in the management of osteoporosis. Indian journal of endocrinology and metabolism, 20(6), 846-852. https://doi.org/10.4103/2230-8210.192914
Shetty, Sahana, et al. "Bone turnover markers: Emerging tool in the management of osteoporosis." Indian journal of endocrinology and metabolism vol. 20,6 (2016): 846-852. doi: https://doi.org/10.4103/2230-8210.192914
Shetty S, Kapoor N, Bondu JD, Thomas N, Paul TV. Bone turnover markers: Emerging tool in the management of osteoporosis. Indian J Endocrinol Metab. 2016 Nov-Dec;20(6):846-852. doi: 10.4103/2230-8210.192914. PMID: 27867890; PMCID: PMC5105571.
Copy Download .nbib Format: NLM
Biocalcite, a multifunctional inorganic polymer: Building block for calcareous sponge spicules and bioseed for the synthesis of calcium phosphate-based bone.

Beilstein journal of nanotechnology

Wang X, Schröder HC, Müller WE.
PMID: 24991497
Beilstein J Nanotechnol. 2014 May 12;5:610-21. doi: 10.3762/bjnano.5.72. eCollection 2014.

Calcium carbonate is the material that builds up the spicules of the calcareous sponges. Recent results revealed that the calcium carbonate/biocalcite-based spicular skeleton of these animals is formed through an enzymatic mechanism, such as the skeleton of the siliceous...

Cite
Wang X, Schröder HC, Müller WE. Biocalcite, a multifunctional inorganic polymer: Building block for calcareous sponge spicules and bioseed for the synthesis of calcium phosphate-based bone. Beilstein J Nanotechnol. 2014;5:610-21doi: 10.3762/bjnano.5.72.
Wang, X., Schröder, H. C., & Müller, W. E. (2014). Biocalcite, a multifunctional inorganic polymer: Building block for calcareous sponge spicules and bioseed for the synthesis of calcium phosphate-based bone. Beilstein journal of nanotechnology, 5610-21. https://doi.org/10.3762/bjnano.5.72
Wang, Xiaohong, et al. "Biocalcite, a multifunctional inorganic polymer: Building block for calcareous sponge spicules and bioseed for the synthesis of calcium phosphate-based bone." Beilstein journal of nanotechnology vol. 5 (2014): 610-21. doi: https://doi.org/10.3762/bjnano.5.72
Wang X, Schröder HC, Müller WE. Biocalcite, a multifunctional inorganic polymer: Building block for calcareous sponge spicules and bioseed for the synthesis of calcium phosphate-based bone. Beilstein J Nanotechnol. 2014 May 12;5:610-21. doi: 10.3762/bjnano.5.72. eCollection 2014. PMID: 24991497; PMCID: PMC4077312.
Copy Download .nbib Format: NLM
Potential of recombinant human growth hormone in HIV-associated adipose redistribution syndrome.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Torres RA, Cadman JA.
PMID: 18034560
BioDrugs. 2000 Aug;14(2):83-91. doi: 10.2165/00063030-200014020-00002.

HIV infection recently has been complicated by the emergence of a rare metabolic dysmorphic disorder characterised by fat atrophy, redistribution and accumulation in the setting of hyperlipidaemia and, on occasion, hyperglycaemia. The disorder, sometimes referred to as HIV-associated Adipose...

Cite
Torres RA, Cadman JA. Potential of recombinant human growth hormone in HIV-associated adipose redistribution syndrome. BioDrugs. 2000;14(2):83-91doi: 10.2165/00063030-200014020-00002.
Torres, R. A., & Cadman, J. A. (2000). Potential of recombinant human growth hormone in HIV-associated adipose redistribution syndrome. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 14(2), 83-91. https://doi.org/10.2165/00063030-200014020-00002
Torres, R A, and Cadman, J A. "Potential of recombinant human growth hormone in HIV-associated adipose redistribution syndrome." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 14,2 (2000): 83-91. doi: https://doi.org/10.2165/00063030-200014020-00002
Torres RA, Cadman JA. Potential of recombinant human growth hormone in HIV-associated adipose redistribution syndrome. BioDrugs. 2000 Aug;14(2):83-91. doi: 10.2165/00063030-200014020-00002. PMID: 18034560.
Copy Download .nbib Format: NLM
[PTH].

Clinical calcium

Shimizu M.
PMID: 15775412
Clin Calcium. 2002 Aug;12(8):1148-51. doi: CliCa020811481151.

Injectable forms of parathyroid hormone (PTH) and its N-terminal fragments are bone anabolic agents proven by randomized clinical trials. Alternate delivery forms of parathyroid hormone are under clinical or preclinical studies, including nasal, transdermal, and pulmonary formulations of PTH...

Cite
Shimizu M. [PTH]. Clin Calcium. 2002;12(8):1148-51doi: CliCa020811481151.
Shimizu, M. (2002). [PTH]. Clinical calcium, 12(8), 1148-51. https://doi.org/CliCa020811481151
Shimizu, Masaru. "[PTH]." Clinical calcium vol. 12,8 (2002): 1148-51. doi: https://doi.org/CliCa020811481151
Shimizu M. [PTH]. Clin Calcium. 2002 Aug;12(8):1148-51. doi: CliCa020811481151. Japanese. PMID: 15775412.
Copy Download .nbib Format: NLM
Burns.

Current opinion in anaesthesiology

Carl P, Reich H.
PMID: 17013217
Curr Opin Anaesthesiol. 1998 Apr;11(2):181-4. doi: 10.1097/00001503-199804000-00011.

Inhalation injuries still significantly increase the morbidity and mortality of burn patients. Advances in ventilatory support appear to decrease the frequency of pneumonia and improve the survival of patients. It is now well accepted that early enteral feeding of...

Cite
Carl P, Reich H. Burns. Curr Opin Anaesthesiol. 1998;11(2):181-4doi: 10.1097/00001503-199804000-00011.
Carl, P., & Reich, H. (1998). Burns. Current opinion in anaesthesiology, 11(2), 181-4. https://doi.org/10.1097/00001503-199804000-00011
Carl, P, and Reich, H. "Burns." Current opinion in anaesthesiology vol. 11,2 (1998): 181-4. doi: https://doi.org/10.1097/00001503-199804000-00011
Carl P, Reich H. Burns. Curr Opin Anaesthesiol. 1998 Apr;11(2):181-4. doi: 10.1097/00001503-199804000-00011. PMID: 17013217.
Copy Download .nbib Format: NLM
Effects of amylin and adrenomedullin on the skeleton.

Journal of musculoskeletal & neuronal interactions

Cornish J, Reid IR.
PMID: 15758473
J Musculoskelet Neuronal Interact. 2001 Sep;2(1):15-24.

Amylin and adrenomedullin are related peptides with some homology to both calcitonin and calcitonin gene-related peptide (CGRP). All these peptides have in common a 6-amino acid ring structure at the amino-terminus created by a disulfide bond. In addition, the...

Cite
Cornish J, Reid IR. Effects of amylin and adrenomedullin on the skeleton. J Musculoskelet Neuronal Interact. 2001;2(1):15-24
Cornish, J., & Reid, I. R. (2001). Effects of amylin and adrenomedullin on the skeleton. Journal of musculoskeletal & neuronal interactions, 2(1), 15-24.
Cornish, J, and Reid, I R. "Effects of amylin and adrenomedullin on the skeleton." Journal of musculoskeletal & neuronal interactions vol. 2,1 (2001): 15-24.
Cornish J, Reid IR. Effects of amylin and adrenomedullin on the skeleton. J Musculoskelet Neuronal Interact. 2001 Sep;2(1):15-24. PMID: 15758473.
Copy Download .nbib Format: NLM
Profile of teriparatide in the management of postmenopausal osteoporosis.

International journal of women's health

Sikon A, Batur P.
PMID: 21072295
Int J Womens Health. 2010 Aug 09;2:37-44. doi: 10.2147/ijwh.s4919.

One out of every 2 women within postmenopause are at risk of fracture due to osteoporosis. Fortunately, a growing arsenal of therapies is becoming available to treat this disease and prevent fracture. A new class of anabolic agents has...

Cite
Sikon A, Batur P. Profile of teriparatide in the management of postmenopausal osteoporosis. Int J Womens Health. 2010;2:37-44doi: 10.2147/ijwh.s4919.
Sikon, A., & Batur, P. (2010). Profile of teriparatide in the management of postmenopausal osteoporosis. International journal of women's health, 237-44. https://doi.org/10.2147/ijwh.s4919
Sikon, Andrea, and Batur, Pelin. "Profile of teriparatide in the management of postmenopausal osteoporosis." International journal of women's health vol. 2 (2010): 37-44. doi: https://doi.org/10.2147/ijwh.s4919
Sikon A, Batur P. Profile of teriparatide in the management of postmenopausal osteoporosis. Int J Womens Health. 2010 Aug 09;2:37-44. doi: 10.2147/ijwh.s4919. PMID: 21072295; PMCID: PMC2971740.
Copy Download .nbib Format: NLM
Anabolic therapy for osteoporosis.

Women's health (London, England)

Bilezikian JP.
PMID: 19803856
Womens Health (Lond). 2007 Mar;3(2):243-53. doi: 10.2217/17455057.3.2.243.

Antiresorptive agents for osteoporosis are a cornerstone of therapy, but anabolic drugs have recently increased our options. By directly stimulating bone formation, anabolic agents reduce fracture incidence by improving bone qualities as well as increasing bone mass. The anabolic...

Cite
Bilezikian JP. Anabolic therapy for osteoporosis. Womens Health (Lond). 2007;3(2):243-53doi: 10.2217/17455057.3.2.243.
Bilezikian, J. P. (2007). Anabolic therapy for osteoporosis. Women's health (London, England), 3(2), 243-53. https://doi.org/10.2217/17455057.3.2.243
Bilezikian, John P. "Anabolic therapy for osteoporosis." Women's health (London, England) vol. 3,2 (2007): 243-53. doi: https://doi.org/10.2217/17455057.3.2.243
Bilezikian JP. Anabolic therapy for osteoporosis. Womens Health (Lond). 2007 Mar;3(2):243-53. doi: 10.2217/17455057.3.2.243. PMID: 19803856.
Copy Download .nbib Format: NLM
Body composition of HIV-infected male adults with wasting syndrome.

Asia Pacific journal of clinical nutrition

Ellis KJ, Shypailo RJ, Pivarnik JM, Jenks BH, Walzel P, Lee PD.
PMID: 24394262
Asia Pac J Clin Nutr. 1995 Mar;4(1):105-8.

Chronic weight loss is a common characteristic of HIV infection; its full etiology remains unknown. We report body composition measurements for 39 adult males with wt loss >= 10% or a body mass index (BMI) below 19.8 kg •...

Cite
Ellis KJ, Shypailo RJ, Pivarnik JM, et al. Body composition of HIV-infected male adults with wasting syndrome. Asia Pac J Clin Nutr. 1995;4(1):105-8
Ellis, K. J., Shypailo, R. J., Pivarnik, J. M., Jenks, B. H., Walzel, P., & Lee, P. D. (1995). Body composition of HIV-infected male adults with wasting syndrome. Asia Pacific journal of clinical nutrition, 4(1), 105-8.
Ellis, K J, et al. "Body composition of HIV-infected male adults with wasting syndrome." Asia Pacific journal of clinical nutrition vol. 4,1 (1995): 105-8.
Ellis KJ, Shypailo RJ, Pivarnik JM, Jenks BH, Walzel P, Lee PD. Body composition of HIV-infected male adults with wasting syndrome. Asia Pac J Clin Nutr. 1995 Mar;4(1):105-8. PMID: 24394262.
Copy Download .nbib Format: NLM
Spontaneous corpus cavernosum abscess in a healthy man using long-term androgenic anabolic steroids.

The world journal of men's health

Tüzel E.
PMID: 25927061
World J Mens Health. 2015 Apr;33(1):36-8. doi: 10.5534/wjmh.2015.33.1.36. Epub 2015 Apr 23.

Abscess formation of the corpus cavernosum is very rare. Here, we report a case of long-term anabolic androgenic steroid (AAS) abuse that is suspected to have facilitated the development of a corpus cavernosum abscess in a healthy bodybuilder. Cultures...

Cite
Tüzel E. Spontaneous corpus cavernosum abscess in a healthy man using long-term androgenic anabolic steroids. World J Mens Health. 2015;33(1):36-8doi: 10.5534/wjmh.2015.33.1.36.
Tüzel, E. (2015). Spontaneous corpus cavernosum abscess in a healthy man using long-term androgenic anabolic steroids. The world journal of men's health, 33(1), 36-8. https://doi.org/10.5534/wjmh.2015.33.1.36
Tüzel, Emre. "Spontaneous corpus cavernosum abscess in a healthy man using long-term androgenic anabolic steroids." The world journal of men's health vol. 33,1 (2015): 36-8. doi: https://doi.org/10.5534/wjmh.2015.33.1.36
Tüzel E. Spontaneous corpus cavernosum abscess in a healthy man using long-term androgenic anabolic steroids. World J Mens Health. 2015 Apr;33(1):36-8. doi: 10.5534/wjmh.2015.33.1.36. Epub 2015 Apr 23. PMID: 25927061; PMCID: PMC4412006.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 114 entries